Drug of Abuse Testing Market To Generate $10,485.7 Million Revenue by 2030
- Published: January 2023
The drug of abuse testing market size is expected to advance at a CAGR of 6.5% during 2022–2030, to reach USD 10,485.7 million by 2030. This is ascribed to the rapid use of drug of abuse testing at the organizational level, due to the increasing consumption of illegal drugs.
Increasing Production and Trade of Illicit Drugs Worldwide
The increasing production and trafficking of illegal drugs are primarily expected to drive the growth of the global market. According to the UNODC, in Afghanistan, opium acreage increased by 32%, to 233,000 hectares, in 2022 compared to 2021 levels. Moreover, the prices of opium have increased with the announcement of the ban on the cultivation of poppy in April. Moreover, the income of farmers in Afghan from the sales of this product more than tripled from USD 425 million in 2021 to USD 1.4 billion in 2022, as Afghanistan supplies 80% of the global opiates.
The extent of drug seizures can be used as an indirect measure of the level of their trade worldwide. Moreover, the largest producer is the Shan state of Myanmar, within the infamous Golden Triangle of illegal drugs, at the tri-junction of the Lao, Burmese, and Thai borders. Drugs from the Golden Triangle had flooded the international market long before Afghanistan started producing them in the 1990s.
APAC Is Fastest-Growing Region in Drug of Abuse Testing Market
APAC is the fastest-growing region, at a CAGR of more than 7%, attributed to the rise in the use of illicit drugs and alcohol in the region. Additionally, the strict government regulations on testing for alcohol consumption are further contributing to the growth of the market in Asia-Pacific.
For instance, in China, 54,000 drug-related cases were solved, 77,000 suspects were arrested, 27 tons of drugs were seized, and 326,000 persons were identified as using drugs in 2021. These efforts reflect the growing focus on DOA testing across the region, which is also the largest producer of such substances.
The market is also growing in Europe, ascribed to the increasing trade and consumption of illicit drugs and rising compliance of organizations with regulations on workplace DOA testing. The extent of drug utilization depends upon drug policies, availability of these substances, and nearness of users to the source of trade. According to the European Monitoring Centre for Drugs and Drug Addiction, around 15.5% of the population in the age group 15–34 years in the region used cannabis in 2021.
Increasing Number of Product Launches
As the consumption of drugs is increasing, it has become necessary for people to keep a check on if anyone around them is consuming such substances or not. In order to achieve this objective, life science companies are bringing about advancements in their DOA testing instruments and consumables. For instance, in December 2022, a new roadside drug testing system was launched at University College Cork in Ireland, because of the 86 fatalities and 765 serious injuries around Christmas and the New Year over the last five years.
Furthermore, 146 road deaths took place in 2022, up by 27 the previous year. The test was launched during Garda Síochána’s one-and-a-half-month-long Christmas road safety campaign.
The most-significant drug of abuse testing market players are Danaher Corporation; Quest Diagnostics Incorporation; Laboratory Corporation of America Holdings; Drägerwerk AG & Co. KGaA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Merck KGaA; Clinical Reference Laboratory (CRL) Inc.; and Omega Laboratories Inc.